GMG wins U.S. EPA approval to start graphene coating sales in the American HVAC market

Graphene Manufacturing Group has cleared a major commercialization hurdle in the United States, saying on March 16, 2026, that the Environmental Protection Agency approved the import and sale of its THERMAL-XR graphene-based coating system. The consent order opens the door to commercial sales in a market the company describes as the largest HVAC-R coating segment in the world.

EPA consent order opens the U.S. market

The approval covers the chemical substance used in GMG’s THERMAL-XR ENHANCE coating system under a pre-manufacture notice filed with the EPA. GMG said the order authorizes export, distribution, sale, use and disposal of the substance in the United States, subject to the conditions set out by the agency.

For GMG, the significance is not the chemistry alone but the regulatory gate it has now passed. The company and its exclusive North American distributor, Nu-Calgon, can now move from clearance to commercial sales in the U.S., where HVAC-R, data center cooling, LNG facilities, automotive and electronics are among the targeted applications.

THERMAL-XR moves from approval to market rollout

GMG has framed THERMAL-XR as part of its broader graphene commercialization effort, pairing materials development with practical industrial use cases. The coating is designed for thermal-management applications, and the company has long positioned HVAC-R as the most immediate commercial entry point because of the installed base and recurring maintenance demand.

The timing matters because U.S. market access has been one of the key steps separating product development from revenue-generating rollout. With the EPA order in hand, GMG can now pursue sales activity in a market that is large, fragmented and heavily dependent on efficiency gains in existing equipment rather than wholesale hardware replacement.

A narrower but clearer path to graphene revenue

The approval does not solve every scale-up challenge, but it gives GMG a concrete commercial lane for one of its graphene products. That is important in a sector where many graphene companies still rely on pilot plants, research partnerships or future-facing claims rather than regulated product access and repeat customer adoption.

GMG has also been advancing its graphene manufacturing capacity in Australia, including work on its Gen 2.0 plant, which the company says is intended to support broader production and commercialization efforts. The U.S. clearance gives the company a regulatory foundation to pair that supply side with a defined sales channel.

For the graphene market more broadly, the milestone is another sign that commercialization is increasingly being measured not by lab performance, but by the slower, less glamorous steps of approval, distribution and field deployment.